Goey, Kaitlyn K H
Elias, Sjoerd G
Hinke, Axel
van Oijen, Martijn G H
Punt, Cornelis J A
Hegewisch-Becker, Susanna
Arnold, Dirk
Koopman, Miriam
Article History
Received: 7 July 2017
Revised: 11 September 2017
Accepted: 9 October 2017
First Online: 9 November 2017
Competing interests
: AH has received honoraria for speaker activities from Roche. SHB has acted in an advisory role for Roche, Merck, Amgen and Lilly. DA has received honoraria for participation in advisory boards from Roche, Merck, Servier and Bayer, and honoraria for speaker activities from Roche, Sanofi, Merck, Servier and Bayer. CJAP has acted in an advisory role for Servier and Nordic Pharma. MK has acted in an advisory role for Servier. The remaining authors have declared no conflict of interest.